Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice.
Martos-Guillami N, Vergara A, Llorens-Cebrià C, Motto AE, Martínez-Díaz I, Gonçalves F, Garcias-Ramis MM, Allo-Urzainqui E, Narváez A, Bermejo S, Muñoz V, León-Román J, Ferrer-Costa R, Jacobs-Cachá C, Vilardell-Vilà J, Soler MJ. Martos-Guillami N, et al. Among authors: soler mj. Front Pharmacol. 2024 Oct 7;15:1415879. doi: 10.3389/fphar.2024.1415879. eCollection 2024. Front Pharmacol. 2024. PMID: 39434906 Free PMC article.
Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction-a substudy of the DAPA-VO2 study.
Mora-Fernández C, Pérez A, Mollar A, Palau P, Amiguet M, de la Espriella R, Sanchis J, Górriz JL, Soler MJ, Navarro-González JF, Núñez J; DAPA-VO2 Investigators; DAPA-VO Investigators. Mora-Fernández C, et al. Among authors: soler mj. Front Cardiovasc Med. 2023 Aug 25;10:1242108. doi: 10.3389/fcvm.2023.1242108. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37745119 Free PMC article.
Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status.
Lorenzo M, Jacobs-Cachá C, Palau P, Amiguet M, Seller J, Núñez E, Espriella R, Górriz JL, Miñana G, Sanchis J, Bayés-Genis A, Soler MJ, Packer M, Núñez J; DAPA-VO2 Investigators. Lorenzo M, et al. Among authors: soler mj. JACC Heart Fail. 2023 Nov;11(11):1611-1622. doi: 10.1016/j.jchf.2023.07.010. Epub 2023 Sep 6. JACC Heart Fail. 2023. PMID: 37676213 Free article. Clinical Trial.
Diagnosis and Treatment of Renal ANCA Vasculitis: A Summary of the Consensus Document of the Catalan Group for the Study of Glomerular Diseases (GLOMCAT).
Draibe JB, Marco H, Ibernon M, Agraz I, Arcal C, Barros X, Cabrera V, Da Silva I, Díaz M, Fulladosa X, Guillén E, Lescano P, Valenzuela LM, Márquez E, Martín N, Merino A, Navarro M, Rodríguez E, Soler MJ, Torras J, Quintana LF, On Behalf Of The Catalan Society Of Nephrology. Draibe JB, et al. Among authors: soler mj. J Clin Med. 2024 Nov 12;13(22):6793. doi: 10.3390/jcm13226793. J Clin Med. 2024. PMID: 39597938 Free PMC article. Review.
Prediabetes and CKD: Does a causal relationship exist.
Rico Fontalvo J, Soler MJ, Daza Arnedo R, Navarro-Blackaller G, Medina-González R, Rodríguez Yánez T, Cardona-Blanco M, Cabrales-Juan J, Uparrela-Gulfo I, Chávez-Iñiguez JS. Rico Fontalvo J, et al. Among authors: soler mj. Nefrologia (Engl Ed). 2024 Sep-Oct;44(5):628-638. doi: 10.1016/j.nefroe.2024.11.005. Nefrologia (Engl Ed). 2024. PMID: 39547776 Free article. Review.
Multidisciplinary Delphi consensus on challenges and key factors for an optimal care model in chronic kidney disease.
Górriz JL, Alcázar Arroyo R, Arribas P, Artola S, Cinza-Sanjurjo S, la Espriella R, Escalada J, García-Matarín L, Martínez L, Julián JC, Miramontes-González JP, Rubial F, Salgueira M, Soler MJ, Trillo JL. Górriz JL, et al. Among authors: soler mj. Nefrologia (Engl Ed). 2024 Sep-Oct;44(5):678-688. doi: 10.1016/j.nefroe.2024.09.004. Epub 2024 Nov 5. Nefrologia (Engl Ed). 2024. PMID: 39505678 Free article.
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial.
Apperloo EM, Gorriz JL, Soler MJ, Cigarrán Guldris S, Cruzado JM, Puchades MJ, López-Martínez M, Waanders F, Laverman GD, van der Aart-van der Beek A, Hoogenberg K, van Beek AP, Verhave J, Ahmed SB, Schmieder RE, Wanner C, Cherney DZI, Jongs N, Heerspink HJL. Apperloo EM, et al. Among authors: soler mj. Nat Med. 2024 Oct 25. doi: 10.1038/s41591-024-03327-6. Online ahead of print. Nat Med. 2024. PMID: 39455729
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial.
Lafayette R, Tumlin J, Fenoglio R, Kaufeld J, Pérez Valdivia MÁ, Wu MS, Susan Huang SH, Alamartine E, Kim SG, Yee M, Kateifides A, Rice K, Garlo K, Barratt J; SANCTUARY Study Investigators. Lafayette R, et al. J Am Soc Nephrol. 2024 Oct 25. doi: 10.1681/ASN.0000000534. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39455063 No abstract available.
290 results